Chronic Pulmonary Sarcoidosis clinical trials

Explore recruiting chronic pulmonary sarcoidosis clinical trials.

Recruiting chronic pulmonary sarcoidosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Pulmonary Sarcoidosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-blind, Placebo-controlled Phase 2 Study with Open-label Extension to Assess the Efficacy and Safety of Namilumab in Subjects with Chronic Pulmonary Sarcoidosis

Germany, France, Netherlands, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Chronic Pulmonary Sarcoidosis trials by city

Chronic Pulmonary Sarcoidosis in Toronto Chronic Pulmonary Sarcoidosis in Vancouver Chronic Pulmonary Sarcoidosis in Montreal Chronic Pulmonary Sarcoidosis in Calgary Chronic Pulmonary Sarcoidosis in Edmonton Chronic Pulmonary Sarcoidosis in Ottawa Chronic Pulmonary Sarcoidosis in Winnipeg Chronic Pulmonary Sarcoidosis in Quebec City Chronic Pulmonary Sarcoidosis in Hamilton Chronic Pulmonary Sarcoidosis in Kitchener Chronic Pulmonary Sarcoidosis in London Chronic Pulmonary Sarcoidosis in Halifax Chronic Pulmonary Sarcoidosis in New York Chronic Pulmonary Sarcoidosis in Los Angeles Chronic Pulmonary Sarcoidosis in Chicago Chronic Pulmonary Sarcoidosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease